Back
Aehr Test Systems 10K Form
Sell
31
AEHR
Aehr Test Systems
Last Price:
$12.26
Seasonality Move:
2.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-10 | 10Q | AEHR/Aehr Test Systems Quarterly |
2024-01-12 | 10Q | AEHR/Aehr Test Systems Quarterly |
2023-10-12 | 10Q | AEHR/Aehr Test Systems Quarterly |
2023-04-13 | 10Q | AEHR/Aehr Test Systems Quarterly |
2023-01-13 | 10Q | AEHR/Aehr Test Systems Quarterly |
2022-10-14 | 10Q | AEHR/Aehr Test Systems Quarterly |
Receive AEHR News And Ratings
See the #1 stock for the next 7 days that we like better than AEHR
AEHR Financial Statistics
Sales & Book Value
Annual Sales: | $66.2M |
---|---|
Cash Flow: | $-6.2M |
Price / Cash Flow: | 444.54 |
Annual Sales: | $4.15 |
Price / Book: | 2.8 |
Profitability
EPS (TTM): | 0.75000 |
---|---|
Net Income (TTM): | $22M |
Gross Margin: | $32.5M |
Return on Equity: | 20.74% |
Return on Assets: | 17.8% |
Aehr Test Systems Earnings Forecast
Key Aehr Test Systems Financial Ratios
-
The Gross Profit Margin over the past 28 years for AEHR is 49.15%.
-
The Selling, General & Administrative Expenses for AEHR have been equal to 20.76% of Gross Profit Margin.
-
The Research & Development expenses have been 13.17% of Revenue.
-
The Net Earning history of AEHR is 50.07% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 18 years.
Aehr Test Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | AEHR |
CUSIP: | 00760J |
Website: | aehr.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 7.55 |
Quick Ratio: | 3.38 |
Price-to-Earnings
Trailing P/E Ratio: | 10.37 |
---|---|
Forward P/E Ratio: | 29.03 |
AEHR Technical Analysis vs Fundamental Analysis
Sell
31
Aehr Test Systems (AEHR)
is a Sell
Is Aehr Test Systems a Buy or a Sell?
-
Aehr Test Systems stock is rated a SellThe current Aehr Test Systems [AEHR] share price is $11.61. The Score for AEHR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.